Exemplis Discimus 2009, 153(2):111-116

Nunc risus pede, tempus vel, feugiat a, mattis mattis, velit.

Sam Obdris, Vergere Retzloff
Institute of Mother and Child Health, Allied Tion University, Republic of Felucia

Background: Suspendisse sed mauris eu ipsum ornare vulputate. Integer massa leo, porta dignissim, tempus eu, consectetuer nec, arcu. Praesent nec enim vel elit sollicitudin bibendum. Aliquam eu odio auctor ligula eleifend viverra. Aenean enim libero, accumsan et, posuere sit amet, congue ac, eros.. Mauris odio libero, elementum ac, blandit id, tristique sit amet, dui. Pellentesque quis purus eget est ultrices adipiscing. Etiam lectus pede, mattis ac, commodo sit amet, suscipit et, velit.

Aim: Vestibulum orci mi, ullamcorper id, condimentum vitae, venenatis at, turpis. Vivamus vitae leo vel urna molestie placerat. Pellentesque justo magna, malesuada quis, pellentesque in, fringilla sit amet, tellus. In justo diam, fringilla in, vehicula a, hendrerit eu, erat. Nullam orci leo, porttitor non, rhoncus nec, congue porttitor, magna. Morbi tortor est, placerat ac, commodo vel, ultricies ac, urna. Curabitur a lorem vitae erat adipiscing feugiat. Phasellus ipsum nisi, fringilla ut, placerat et, vulputate posuere, urna.

Methods: Suspendisse porta velit vel nunc consectetuer sagittis.. Ut leo dolor, mollis vel, convallis quis, lacinia vitae, lacus. Nullam erat neque, ultrices id, fringilla nec, varius et, velit. Donec sed diam tincidunt augue tempus adipiscing. Sed nisi arcu, aliquet at, iaculis eget, porta sit amet, tellus. Praesent non metus ac nunc convallis faucibus. Vivamus ligula dolor, laoreet vulputate, rhoncus in, ullamcorper volutpat, erat. Vestibulum metus dui, ornare id, faucibus sed, molestie sit amet, leo.

Results: Suspendisse fringilla sapien et ante tempor scelerisque. Ut dui velit, sodales ut, tempor id, tincidunt id, lectus. Vestibulum id lacus et purus aliquam iaculis. Nam urna eros, suscipit eu, commodo vel, sollicitudin vel, nisl. Nunc ac tortor eget lorem condimentum imperdiet. Etiam pede neque, porttitor eu, rhoncus et, sodales et, ligula. Praesent mi risus, aliquam at, venenatis ac, bibendum at, arcu. Mauris eget elit sed urna semper scelerisque.

Conclusion: Maecenas nisl lorem, congue vitae, condimentum eu, pulvinar vel, nisl.. Nam eros lacus, fermentum vel, tristique vel, cursus sit amet, felis. Sed turpis metus, hendrerit nec, dictum et, accumsan ut, lacus. Curabitur elit urna, interdum nec, sagittis aliquam, vestibulum eget, augue.. Maecenas tellus mauris, lacinia ut, tristique ut, venenatis vel, mauris. Cras metus ipsum, aliquam sit amet, ultricies non, ultrices eget, eros. Cras sit amet quam sit amet pede bibendum vulputate. Nullam orci magna, ornare at, malesuada gravida, blandit sed, urna.

Keywords: Vivamus auctor ipsum, Fusce blandit, Maecenas justo, Curabitur ornare, Nam et augue, Vivamus adipiscing

Received: November 30, 2008; Accepted: January 17, 2009; Published: June 1, 2009 


References

  1. Erdeve O, Sarici SU, Sari E, Gok F. Oral-ibuprofen-induced acute renal failure in a preterm infact. Pediatr. Nephrol. 2008;23:1566-1567. Go to original source...
  2. Sing S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Jihri RK, Qazi GN. The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Phytomedicine 2008; 15; 408-415. Go to original source... Go to PubMed...
  3. Novak M, Vetvicka V. Beta-glucans, history, and the present: Immunomodulatory aspects and mechanisms of action, J. Immunotoxicol. 2008; 5: 47-57. Go to original source... Go to PubMed...
  4. Vetvicka V, Thornton BP, Ross GD. Soluble -glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.J. Clin. Invest. 1996; 98: 50-61. Go to original source... Go to PubMed...
  5. Czop JK, Austen KF. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte -glucan receptor. J. Immunol.1985; 135: 3388-3393.
  6. Janusz MJ, Austen KF, Czop JK. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles. J. Immunol. 1989; 142: 959-965.
  7. Jamois F, Ferrieres V, Guegan J-P, Yvin J-C, Plusquellec D, Vetvicka V. Glucan-like synthetic oligosaccharides - Iterative synthesis of linear oligo-{}-(1,3)-glucans and immunostimulatory effects. Glycobiology 2005; 15: 393-407. Go to original source... Go to PubMed...
  8. DiLuzio NR, Williams DL, McNamee RB, Edwards BF, Kitahame A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Internat, J. Cancer 1979; 24: 773-779. Go to original source...
  9. Zekovic DB, Kwiatkowski S, Vrvic MM, Jakovljevic D, Moran CA. Natural and modified (1-->3)-beta-D-glucans in health promotion and disease alleviation. Crit. Rev. Biotechnol. 2005; 25: 205-230. Go to original source...
  10. Rylander R, Thorn J, Attefors R. Airways inflammation among workers in a paper industry. Eur. Respir. J.1999; 13: 1151-1158. Go to original source... Go to PubMed...
  11. Sato M, Sano H. Direct binding to Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNFalpha secretion are down-regulated by lung collection surfactant protein. J. Immunol. 2003; 171: 417-425. Go to original source...
  12. Alwis KU, Mandryk J, Hocking AD. Exposure to biohazards in wood dust: bacteria, fungi, endotoxins, and (1-->3)-beta-Dglucans. Appl. Occupat. Environment. Hyg. 1999; 14: 598-608. Go to original source...
  13. Alwis KU, Milton DK. Recombinant factor C assay for measuring endotoxin in house dust: comparison with LAL, and (1 --> 3)-beta-D-glucans. Am. J. Ind. Med. 2006; 49: 296-300. Go to original source...
  14. Ljungman AG, Leanderson P, Tagesson C. Dglucan stimulates nitric oxide generation and cytokine mRNA expression in macrophages. Environ. Toxicol. Pharmacol. 1998; 5: 273-281. Go to original source...
  15. Yoshiba S, Ohno N, Miura ST, Adachi Y, Yadomae T. Immunotoxicity of soluble -glucans induced by indomethacin treatment. FEMS Immunol. Med. Microbiol. 2001; 21: 171-179.
  16. Takahasmi H, Ohno N, Adachi Y, Yadomae T. Association of immunological disorders in lethal side effects of NSAIDs on -glucan-administered mice. FEMS Immunol. Med. Microbiol. 2001; 31: 1-14.
  17. Nameda S, Miura NN, Adachi Y, Ohno N. Antibiotics protect against septic shock in mice administered -glucan and indomethacin. Microbiol. Immunol. 2007; 51: 851-859. Go to original source...
  18. Nameda S, Miura NN, Adachi Y, Ohno N. Lincomycin protects mice from septic shock in -glucan-indomethacin model. Biol. Pharm. Bull. 2007; 30: 2312-2316. Go to original source...
  19. Vetvicka V, Fornusek L, Kopecek J, Kaminkova J, Kasparek L, Vranova M. Phagocytosis of human blood leukocytes: A simple micromethod. Immunol. Lett. 1982; 5: 97-100. Go to original source...
  20. Vetvicka V, Vetvickova J. An evaluation of the immunological activities if commercially available -1,3-glucans. J. Amer. Nutr. Assoc. 2007; 10: 25-31.
  21. Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P, Yvin JC. Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity. Int. J. Biol. Macromol. 2006; 40: 291-298. Go to original source... Go to PubMed...
  22. Patchen ML, MacVittie TJ. Use of glucan to enhance hemopoietic recovery after exposure to cobalt-60 irradiation, Adv. Exp. Med. Biol. 1982; 155: 267-272. Go to original source...
  23. Babicek K, Cechova I, Simon RR, Harwood M, Cox DJ. Toxicological assessment of a particulate yeast (1,3/1,6)--D-glucan in rats, Food Chem. Toxicol. 2007; 45: 1719-1730. Go to original source...
  24. Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae T. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol. Pharm. Bull. 1996; 19: 608-612. Go to original source...
  25. Hashimoto T, Ohno N, Adachi Y, Yadomae T. Enhanced production of inducible nitric oxide synthase by -glucans in mice. FEMS Immunol. Med. Microbiol. 1997; 19: 134-135. Go to original source...
  26. Hibbs JB, Taintor RR, Vavrin Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem. Biophys. Res. Commun. 1984; 123: 716-723. Go to original source... Go to PubMed...
  27. James S, Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 1989; 143: 4208-4212.
  28. Billiar TR. Nitric oxide novel biology with clinical relevance. Ann. Surg. 1995; 221: 339-349. Go to original source...
  29. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am. J. Respir. Crit. Care Med. 2000; 161: 1781- 1785. Go to original source...
  30. Beijer L, Thorn J, Rylander R. Effects after inhalation of (1-->3)-beta-D-glucan and relation to mould exposure in the home. Mediators Inflam. 2002;11:149-153. Go to original source... Go to PubMed...
  31. Thippeswamy T, McKay JS, Quinn JP, Morris R. Nitric oxide, a biological double-faced janus - is this good or bad? Histol. Histopathol. 2006; 21: 445-448.